Neo Ivy Capital Management

Position in BRKR — Bruker Corp

CIK 1727783 NEW YORK, NY

Position in BRKR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,169,259

+$4,139,280 QoQ

Shares Held

115,428

+28191.2% QoQ

Ownership

0.074%

of shares outstanding

% of Portfolio

1.12%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Neo Ivy Capital Management holds $4,686,677 across 2 Medical Devices names.

#	Ticker	Company	Shares	Value (USD)	Open
1	GEHC	GE HealthCare Technologies Inc.	47,310	$3,028,313
2	ABT	Abbott Laboratories	18,276	$1,658,364

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,169,259	115,428	+28191.2%	Shares	Sole	2026-05-15
2023-12-31	$29,979	408	-62.2%	Shares	Sole	2024-02-26
2022-09-30	$57,251	1,079	-36.5%	Shares	Sole	2022-11-16
2022-03-31	$109,310	1,700	+470.5%	Shares	Sole	2022-05-16
2021-12-31	$25,005	298	-97.2%	Shares	Sole	2022-02-15
2021-09-30	$841,449	10,774	+412.6%	Shares	Sole	2021-11-16
2020-09-30	$83,554	2,102	-80.5%	Shares	Sole	2020-11-17
2020-06-30	$438,286	10,774	—	Shares	Sole	2020-08-17
No filing history on record for this holder in this stock.